Abbott Laboratories - 37 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of February 20, 2020 is 88.46.
- The all-time high Abbott Laboratories stock closing price was 91.86 on January 22, 2020.
- The Abbott Laboratories 52-week high stock price is 92.45, which is 4.5% above the current share price.
- The Abbott Laboratories 52-week low stock price is 72.36, which is 18.2% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 82.87.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2020 | 88.2162 | 86.9500 | 91.8600 | 85.1200 | 88.4600 | 1.84% |
| 2019 | 80.5399 | 69.5000 | 88.7400 | 66.2200 | 86.8600 | 20.09% |
| 2018 | 64.2198 | 58.7900 | 74.2700 | 56.2700 | 72.3300 | 26.74% |
| 2017 | 48.5437 | 39.0500 | 57.4700 | 39.0500 | 57.0700 | 48.58% |
| 2016 | 40.4946 | 42.9300 | 45.2900 | 36.3400 | 38.4100 | -14.47% |
| 2015 | 46.3063 | 44.9000 | 51.2000 | 39.0600 | 44.9100 | -0.24% |
| 2014 | 40.9592 | 38.2300 | 46.3700 | 35.8500 | 45.0200 | 17.45% |
| 2013 | 35.6540 | 32.0500 | 38.7100 | 32.0500 | 38.3300 | -41.48% |
| 2012 | 62.7592 | 56.7200 | 72.1300 | 54.1500 | 65.5000 | 16.49% |
| 2011 | 51.0656 | 47.8200 | 56.3300 | 45.1600 | 56.2300 | 17.37% |
| 2010 | 50.7320 | 54.4600 | 56.2400 | 45.8600 | 47.9100 | -11.26% |
| 2009 | 48.4288 | 53.5600 | 57.2500 | 41.5200 | 53.9900 | 1.16% |
| 2008 | 55.1625 | 55.8100 | 60.5000 | 49.4500 | 53.3700 | -4.95% |
| 2007 | 54.4193 | 48.9700 | 59.4300 | 48.9700 | 56.1500 | 15.27% |
| 2006 | 45.0284 | 39.5500 | 49.4800 | 39.5500 | 48.7100 | 23.54% |
| 2005 | 45.3700 | 46.6700 | 49.9900 | 37.6300 | 39.4300 | -15.48% |
| 2004 | 42.3562 | 46.7500 | 46.9900 | 38.3600 | 46.6500 | 0.11% |
| 2003 | 41.2727 | 40.0500 | 47.1500 | 34.3800 | 46.6000 | 16.50% |
| 2002 | 45.8684 | 55.8400 | 57.7000 | 31.0000 | 40.0000 | -28.25% |
| 2001 | 50.0663 | 48.1300 | 56.7700 | 42.0600 | 55.7500 | 15.09% |
| 2000 | 41.6982 | 35.0000 | 55.7500 | 29.6300 | 48.4400 | 33.41% |
| 1999 | 43.6333 | 48.7500 | 52.9400 | 33.3100 | 36.3100 | -25.90% |
| 1998 | 40.9077 | 33.7200 | 49.7500 | 33.3450 | 49.0000 | 49.62% |
| 1997 | 30.8148 | 25.1900 | 34.3150 | 25.1900 | 32.7500 | 29.06% |
| 1996 | 22.6483 | 20.8750 | 28.3750 | 19.3750 | 25.3750 | 21.91% |
| 1995 | 19.2416 | 16.3150 | 22.3150 | 15.6250 | 20.8150 | 27.58% |
| 1994 | 14.8357 | 14.4400 | 16.8150 | 13.0650 | 16.3150 | 10.12% |
| 1993 | 13.4211 | 15.1900 | 15.1900 | 11.5000 | 14.8150 | -2.47% |
| 1992 | 15.3475 | 16.8125 | 17.0300 | 13.5000 | 15.1900 | -11.78% |
| 1991 | 13.0176 | 10.8125 | 17.2175 | 9.9375 | 17.2175 | 53.04% |
| 1990 | 9.5320 | 8.6563 | 11.3750 | 7.8750 | 11.2500 | 32.35% |
| 1989 | 7.3855 | 5.9688 | 8.7663 | 5.8288 | 8.5000 | 41.28% |
| 1988 | 5.8545 | 6.0788 | 6.5000 | 5.3750 | 6.0163 | -0.25% |
| 1987 | 7.1870 | 5.9375 | 8.3600 | 5.3750 | 6.0313 | 5.74% |
| 1986 | 5.4847 | 4.2500 | 6.7963 | 3.9844 | 5.7038 | 33.48% |
| 1985 | 3.4075 | 2.5394 | 4.3831 | 2.5000 | 4.2731 | 63.76% |
| 1984 | 2.6840 | 2.8750 | 3.0000 | 2.3750 | 2.6094 | -7.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $158.029B | $31.904B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $152.495B | 20.50 |
| Stryker (SYK) | United States | $84.317B | 27.25 |
| Boston Scientific (BSX) | United States | $59.962B | 27.06 |
| Baxter (BAX) | United States | $47.563B | 28.84 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $33.669B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $32.914B | 20.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $31.999B | 0.00 |
| Coloplast (CLPBY) | Denmark | $30.931B | 47.73 |
| Terumo (TRUMY) | Japan | $26.401B | 32.95 |
| ResMed (RMD) | United States | $25.542B | 44.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $21.089B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $18.226B | 0.00 |
| Insulet (PODD) | United States | $13.333B | 634.32 |
| Bio-Rad Laboratories (BIO) | United States | $12.243B | 57.20 |
| Perrigo (PRGO) | Ireland | $8.058B | 15.02 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.606B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.537B | 38.94 |
| Hill-Rom Holdings (HRC) | United States | $7.276B | 20.93 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.161B | 0.00 |
| Haemonetics (HAE) | United States | $6.058B | 37.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Envista Holdings (NVST) | United States | $4.488B | 0.00 |
| ICU Medical (ICUI) | United States | $4.469B | 29.13 |
| NuVasive (NUVA) | United States | $4.132B | 32.54 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.908B | 0.00 |
| Neogen (NEOG) | United States | $3.835B | 63.82 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.660B | 0.00 |
| Quidel (QDEL) | United States | $3.444B | 30.24 |
| Agios Pharmaceuticals (AGIO) | United States | $3.123B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.810B | 63.43 |
| Aurora Cannabis (ACB) | Canada | $1.999B | 0.00 |
| AtriCure (ATRC) | United States | $1.668B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.592B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.556B | 0.00 |
| InMode (INMD) | Israel | $1.249B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.207B | 0.00 |
| Aphria (APHA) | $1.129B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.055B | 20.86 |
| VAREX IMAGING (VREX) | United States | $0.998B | 20.74 |
| PetIQ (PETQ) | United States | $0.983B | 23.99 |
| Cerus (CERS) | United States | $0.828B | 0.00 |
| Quanterix (QTRX) | United States | $0.805B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.723B | 27.68 |
| Omeros (OMER) | United States | $0.669B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.649B | 16.21 |
| LeMaitre Vascular (LMAT) | United States | $0.613B | 34.83 |
| MacroGenics (MGNX) | United States | $0.531B | 0.00 |
| Surmodics (SRDX) | United States | $0.513B | 58.99 |
| OraSure Technologies (OSUR) | United States | $0.439B | 54.77 |
| Organigram Holdings (OGI) | Canada | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.423B | 15.65 |
| HEXO (HEXO) | $0.409B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.356B | 25.29 |
| Meridian Bioscience (VIVO) | United States | $0.348B | 14.02 |
| Zynex (ZYXI) | United States | $0.344B | 38.89 |
| BioLife Solutions (BLFS) | United States | $0.334B | 136.00 |
| Repro-Med Systems (KRMD) | United States | $0.280B | 0.00 |
| Female Health (VERU) | United States | $0.276B | 0.00 |
| Bovie Medical (APYX) | United States | $0.260B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.233B | 1175.00 |
| Viemed Healthcare (VMD) | United States | $0.217B | 22.92 |
| Vapotherm (VAPO) | United States | $0.212B | 0.00 |
| United Health Products (UEEC) | United States | $0.192B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.189B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.189B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.176B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.159B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.132B | 0.00 |
| Fonar (FONR) | United States | $0.130B | 9.48 |
| Chimerix (CMRX) | United States | $0.106B | 0.00 |
| Surface Oncology (SURF) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MRI Interventions (CLPT) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.080B | 20.35 |
| MTech Acquisition (KERN) | United States | $0.076B | 0.00 |
| Nephros (NEPH) | United States | $0.072B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.031B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.021B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| Myomo (MYO) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.002B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
